The Identification of Potent, Selective, and Brain Penetrant PI5P4Kγ Inhibitors as In Vivo-Ready Tool Molecules.

Abstract

Owing to their central role in regulating cell signaling pathways, the phosphatidylinositol 5-phosphate 4-kinases (PI5P4Ks) are attractive therapeutic targets in diseases such as cancer, neurodegeneration, and immunological disorders. Until now, tool molecules for these kinases have been either limited in potency or isoform selectivity, which has hampered further investigation of biology and drug development. Herein we describe the virtual screening workflow which identified a series of thienylpyrimidines as PI5P4Kγ-selective inhibitors, as well as the medicinal chemistry optimization of this chemotype, to provide potent and selective tool molecules for further use. In vivo pharmacokinetics data are presented for exemplar tool molecules, along with an X-ray structure for ARUK2001607 (15) in complex with PI5P4Kγ, along with its selectivity data against >150 kinases and a Cerep safety panel.

• Authors: Timothy P C Rooney, Gregory G Aldred, Helen K Boffey, Henriëtte M G Willems, Simon Edwards, Stephen J Chawner, Duncan E Scott, Christopher Green, David Winpenny, John Skidmore, Jonathan H Clarke, Stephen P Andrews
• Journal: Journal of medicinal chemistry (J Med Chem) Vol. 66 Issue 1 Pg. 804-821 (01 12 2023) ISSN: 1520-4804 [Electronic] United States
• PMID: 36516442 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Protein Isoforms
• Protein Kinase Inhibitors

Topics

• Humans
• Protein Isoforms
• Signal Transduction
• Neoplasms
• Brain
• Protein Kinase Inhibitors (pharmacology, chemistry)